
Kane Biotech
(OTC) KNBIF
Kane Biotech Financials at a Glance
Market Cap
$6.02M
Revenue (TTM)
$427.52K
Net Income (TTM)
$2.72M
EPS (TTM)
$-0.01
P/E Ratio
-3.80
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.03
Volume
30,000
Open
$0.03
Price
$0.03
Volume
30,000
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
Dividend
$0.00
Beta (Volatility)
-0.00 (Low)
Price
$0.03
Volume
30,000
Open
$0.03
Previous Close
$0.03
Daily Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.06
KNBIF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kane Biotech
Industry
Biotechnology
Sector
Health CareCEO
Robert B. Huizinga, PhD
Website
www.kanebiotech.comHeadquarters
Winnipeg, MB R3T 6G2, CA
KNBIF Financials
Key Financial Metrics (TTM)
Gross Margin
-38%
Operating Margin
-7%
Net Income Margin
-6%
Return on Equity
0%
Return on Capital
-13%
Return on Assets
-100%
Earnings Yield
-26.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.02M
Shares Outstanding
181.86M
Volume
30.00K
Avg. Volume
10.68K
Financials (TTM)
Gross Profit
$163.24K
Operating Income
$3.11M
EBITDA
$2.95M
Operating Cash Flow
$3.25M
Capital Expenditure
$4.89K
Free Cash Flow
$3.26M
Cash & ST Invst.
$900.96K
Total Debt
$2.30M
Kane Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.49K
-117.1%
Gross Profit
$155.04K
-77.8%
Gross Margin
7.21%
N/A
Market Cap
$6.02M
N/A
Market Cap/Employee
$300.98K
N/A
Employees
20
N/A
Net Income
$544.64K
+49.7%
EBITDA
$1.14M
-19.0%
Quarterly Fundamentals
Net Cash
$1.40M
+22.8%
Accounts Receivable
$36.46K
-58.6%
Inventory
$504.15K
+34.1%
Long Term Debt
$977.91K
-42.9%
Short Term Debt
$1.32M
+186.9%
Return on Assets
-99.53%
N/A
Return on Invested Capital
-13.41%
N/A
Free Cash Flow
$582.74K
-26.4%
Operating Cash Flow
$677.96K
-61.5%